Drugs / Islet Cell Transplant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00566813 Comparator | Nov 2004 → Jul 2010 | type 1 diabetes mellitus | University of Illinois at Chicago | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Islet Cell Transplant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00566813 ↗ |
| Modality | Cell therapy | “1-3 allogeneic islet transplants” NCT00566813 ↗ |
| Route | Other | “received 1-3 intraportal allogeneic islet Tx” PMID 18444920 ↗ Apr 2008 |